Repository logoRepository logo
GRO
  • GRO.data
  • GRO.plan
Help
  • English
  • Deutsch
Log In
New user? Click here to register.Have you forgotten your password?
Publications
Researcher
Organizations
Other
  • Journals
  • Series
  • Events
  • Projects
  • Working Groups

Browsing by Author "Herrmann, Luisa"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Some of the metrics are blocked by your 
    consent settings
    Met carriers of the BDNF Val66Met polymorphism show reduced Glx/NAA in the pregenual ACC in two independent cohorts
    (2021)
    Martens, Louise
    ;
    Herrmann, Luisa
    ;
    Colic, Lejla
    ;
    Li, Meng
    ;
    Richter, Anni
    ;
    Behnisch, Gusalija
    ;
    Stork, Oliver
    ;
    Seidenbecher, Constanze
    ;
    Schott, Björn H.
    ;
    Walter, Martin
    Abstract The Met allele of the Val66Met SNP of the BDNF gene (rs6265) is associated with impaired activity-dependent release of brain-derived neurotrophic factor (BDNF), resulting in reduced synaptic plasticity, impaired glutamatergic neurotransmission, and morphological changes. While previous work has demonstrated Val66Met effects on magnetic resonance spectroscopy (MRS) markers of either glutamatergic metabolism (Glx) or neuronal integrity (NAA), no study has investigated Val66Met effects on these related processes simultaneously. As these metabolites share a metabolic pathway, the Glx/NAA ratio may be a more sensitive marker of changes associated with the Val66Met SNP. This ratio is increased in psychiatric disorders linked to decreased functioning in the anterior cingulate cortex (ACC). In this study, we investigated the correlation of the Val66Met polymorphism of the BDNF gene with Glx/NAA in the pregenual anterior cingulate cortex (pgACC) using MRS at 3 Tesla (T) (n = 30, all males) and 7 T (n = 98, 40 females). In both cohorts, Met carriers had lower Glx/NAA compared to Val homozygotes. Follow-up analyses using absolute quantification revealed that the Met carriers do not show decreased pgACC glutamate or glutamine levels, but instead show increased NAA compared to the Val homozygotes. This finding may in part explain conflicting evidence for Val66Met as a risk factor for developing psychiatric illnesses.

About

About Us
FAQ
ORCID
End User Agreement
Privacy policy
Cookie consent
Imprint

Contact

Team GRO.publications
support-gro.publications@uni-goettingen.de
Matrix Chat: #support_gro_publications
Feedback

Göttingen Research Online

Göttingen Research Online bundles various services for Göttingen researchers:

GRO.data (research data repository)
GRO.plan (data management planning)
GRO.publications (publication data repository)
Logo Uni Göttingen
Logo Campus Göttingen
Logo SUB Göttingen
Logo eResearch Alliance

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 4.0 International license.